Effects of Pergolide Treatment on Metabolic and Immunological Function in Horses with Pituitary Pars Intermedia Dysfunction (PPID)

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/171/1/19

Funding

  • Boehringer Ingelheim Vetmedica: $79,731.00